Compendia Bioscience leverages Web for biodata analysis
A number of startups are starting to bring the power of new Web 2.0 technologies to bear on complex masses of biological data.
One is Compendia Bioscience, an Ann Arbor, Mich., computational biotech that’s focused on mining cancer-genomics data. The company just received a $2.4 million grant from the National Cancer Institute to further development of Compendia’s lead product, a program that combs through and analyzes publicly available data on gene activity in a variety of tumors. David Hamilton at VentureBeat LifeSciences has more about “gene chips,” etc, here.
Next Story: Roundup: [Update: Facebook takes dip, maybe?], Crescendo Ventures, and more
Previous Story: MyLifeBrand, latest social networking site, raises $750,000
About the Author, Matt Marshall
Matt Marshall is editor and CEO of VentureBeat. Follow him on Twitter at @mmarshall, and follow VentureBeat on Twitter at @venturebeat.